H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes
Conclusion:
The majority of patients experienced a timely resolution of their MS relapse with few hyperglycemic adverse events. Although more studies are necessary, these data suggest that Acthar Gel may be a well-tolerated and effective treatment option for patients with diabetes experiencing an MS relapse.
Source: Therapeutic Advances in Chronic Disease - Category: Internal Medicine Authors: Kutz, C. Tags: Original Research Source Type: research
More News: Corticosteroid Therapy | Diabetes | Endocrinology | Hormones | Internal Medicine | Methylprednisolone | Multiple Sclerosis | Prednisone | Study